Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Wilding

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Scientific Reports|October 12, 2019
The adequacy of tissue microarrays in the assessment of inter- and intra-tumoural heterogeneity of infiltrating lymphocyte burden in leiomyosarcomaA T J Lee, W Chew, C P Wilding, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|February 1, 1978
Drug interference in clinical chemistry: studies on ascorbic acidG Siest, W Appel, G B Blijenberg, et al.
Circulation|May 20, 2017
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, et al.
Journal of the American College of Cardiology|June 2, 2018
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REALMatthew A Cavender, Anna Norhammar, Kåre I Birkeland, et al.
Circulation|February 28, 2018
Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, et al.
Diabetes, Obesity & Metabolism|March 24, 2018
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL studyMikhail Kosiborod, Kåre I Birkeland, Matthew A Cavender, et al.
Clinical Science (London, England : 1979)|April 18, 2014
Ectopic lipid storage in non-alcoholic fatty liver disease is not mediated by impaired mitochondrial oxidative capacity in skeletal muscleDaniel J Cuthbertson, Andrew Irwin, Victoria S Sprung, et al.
International Journal of Obesity (2005)|May 15, 2015
Cerebral activations during viewing of food stimuli in adult patients with acquired structural hypothalamic damage: a functional neuroimaging studyC A Steele, J L Powell, G J Kemp, et al.
Journal of Proteomics|April 25, 2021
Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometryMartina Milighetti, Lukas Krasny, Alex T J Lee, et al.
Cancer Medicine|July 23, 2024
Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wallMadhumeeta Chadha, Sara Iadecola, Andrew Jenks, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Scientific Reports|October 12, 2019
The adequacy of tissue microarrays in the assessment of inter- and intra-tumoural heterogeneity of infiltrating lymphocyte burden in leiomyosarcomaA T J Lee, W Chew, C P Wilding, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|February 1, 1978
Drug interference in clinical chemistry: studies on ascorbic acidG Siest, W Appel, G B Blijenberg, et al.
Circulation|May 20, 2017
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, et al.
Journal of the American College of Cardiology|June 2, 2018
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REALMatthew A Cavender, Anna Norhammar, Kåre I Birkeland, et al.
Circulation|February 28, 2018
Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, et al.
Diabetes, Obesity & Metabolism|March 24, 2018
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL studyMikhail Kosiborod, Kåre I Birkeland, Matthew A Cavender, et al.
Clinical Science (London, England : 1979)|April 18, 2014
Ectopic lipid storage in non-alcoholic fatty liver disease is not mediated by impaired mitochondrial oxidative capacity in skeletal muscleDaniel J Cuthbertson, Andrew Irwin, Victoria S Sprung, et al.
International Journal of Obesity (2005)|May 15, 2015
Cerebral activations during viewing of food stimuli in adult patients with acquired structural hypothalamic damage: a functional neuroimaging studyC A Steele, J L Powell, G J Kemp, et al.
Journal of Proteomics|April 25, 2021
Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometryMartina Milighetti, Lukas Krasny, Alex T J Lee, et al.
Cancer Medicine|July 23, 2024
Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wallMadhumeeta Chadha, Sara Iadecola, Andrew Jenks, et al.
Pageof 16